CONDENSED STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Cash Flows From Operating Activities:
Net income		$ 4,769,429
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on Investments held in Trust Account	$ (5,376)	(7,326)
Transaction costs associated with warrant liabilities	591,948	591,948
Change in fair value of derivative liabilities	(5,802,479)	(6,158,319)
Changes in operating assets and liabilities:
Prepaid expenses		(548,007)
Accrued offering costs		431,000
Accounts payable and accrued expenses		603,691
Net Cash Used In Operating Activities		(317,584)
Cash Flows From Investing Activities:
Due from Sponsor		(5,420)
Cash deposited into Trust Account		(230,000,000)
Net Cash Used In Investing Activities		(230,005,420)
Cash Flows From Financing Activities:
Sale of Units in Public Offering, net of underwriting discount		224,350,761
Sale of Private Placement Warrants to Sponsor		6,600,000
Net Cash Provided By Financing Activities		230,950,761
Net change in cash and cash equivalents		627,757
Cash and cash equivalents at beginning of period		25,000
Cash and cash equivalents at end of period	$ 652,757	652,757
Supplemental disclosure of non-cash financing activities:
Initial classification of fair value of Private Warrants		9,770,532
Deferred underwriting compensation charged to additional paid-in capital in connection with the Initial Public Offering		$ 8,050,000